One dose of LSD provides weeks of anxiety relief, study finds
UC expert comments on new study to USA Today
The University of Cincinnati's Jeffrey Strawn was featured in a USA Today article commenting on a new study that found a pharmaceutical version of the psychedelic LSD might help alleviate anxiety symptoms for up to three months.
Study results were published Sept. 4 in the journal JAMA. The Phase 2, randomized clinical trial evaluated MM120, a pharmaceutical version of LSD, or lysergide D-tartrate, in 198 adults who had generalized anxiety disorder. After 12 weeks, anxiety symptoms improved in 65% of adults who took a single, 100-mg dose of the drug compared to 30.8% who took a placebo.
The study reported a "remission" rate of 47.5% among adults 12 weeks after taking a single dose compared to 20% who took a placebo. More than nine in 10 people on the 100-mg dose experience hallucinations, with other common side effects including nausea and headaches.
Strawn was not involved in the study, but oversees a clinical trial site for one of MM120's current Phase 3 studies. He said the study is "really important," as anxiety treatments have "really not significantly changed in decades."
"This is a disorder where often we are frustrated as clinicians marching through multiple treatments that don't work or produce side effects," Strawn, MD, professor in the Department of Psychiatry and Behavioral Neuroscience in UC’s College of Medicine and a UC Health child and adolescent psychiatrist, told USA Today. "Also, our patients are frustrated."
Featured photo at top of Dr. Strawn. Photo/Colleen Kelley/UC Marketing + Brand.
Related Stories
CCM welcomes new film and media scoring faculty member J.R. Paredes
May 20, 2026
UC College-Conservatory of Music Dean Pete Jutras has announced the appointment of J.R. Paredes as CCM's new Assistant Professor of Film and Media Scoring. His faculty appointment officially begins on Aug. 15, 2026. Paredes is a composer, music producer and audio post-production specialist whose work spans film, television and commercial music. His credits include original scores for feature films and series distributed on platforms such as Apple TV+ and Prime Video, as well as extensive work in sound design and mixing for film and media.
6 ways starting a GLP-1 medication could affect your emotions
May 20, 2026
When patients first start taking a glucagon-like peptide-1 (GLP-1) medication, they probably expect to feel full. But they might not anticipate how it can influence their emotions. The medications act on the stomach and the brain, said Malti Vij, MD, a University of Cincinnati adjunct associate professor in the College of Medicine's Department of Internal Medicine and a diplomate of the American Board of Obesity Medicine.